Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
about
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@ast
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@en
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@nl
type
label
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@ast
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@en
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@nl
prefLabel
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@ast
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@en
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@nl
P2093
P2860
P921
P3181
P1433
P1476
Defining the Active Fraction o ...... c and Pharmacodynamic Approach
@en
P2093
Alan Forrest
Brian T Tsuji
Patricia N Holden
Samira M Garonzik
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0156131
P407
P577
2016-01-01T00:00:00Z